Long-Term Vision: Evolution Beyond Seven Models

The seven-model lineup likely represents an intermediate step rather than final destination in the product line’s evolution. Future iterations may expand further or consolidate based on market feedback and technological developments.
Emerging technologies like augmented reality displays, advanced health sensors, or modular component systems could spawn entirely new device categories that sit alongside or eventually replace current model types.
Market consolidation remains possible if certain models fail to achieve expected sales volumes or if overlapping specifications create confusion. The company maintains flexibility to adjust the portfolio composition over time based on performance data.
Subscription-based device programs or hardware-as-a-service models could fundamentally alter how consumers interact with the product line, potentially making model selection less critical when regular upgrades are included in service plans.
The ultimate goal appears to be creating a sustainable portfolio that captures maximum market opportunity while remaining operationally manageable. Whether seven proves to be the optimal number or merely a stepping stone toward a different configuration will become clear as the strategy unfolds through 2027 and beyond.